Cargando…

Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol

BACKGROUND: Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mapanga, Witness, Elhakeem, Ahmed, Feresu, Shingairai A., Maseko, Fresier, Chipato, Tsungai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404686/
https://www.ncbi.nlm.nih.gov/pubmed/28438187
http://dx.doi.org/10.1186/s13643-017-0484-9
_version_ 1783231635828768768
author Mapanga, Witness
Elhakeem, Ahmed
Feresu, Shingairai A.
Maseko, Fresier
Chipato, Tsungai
author_facet Mapanga, Witness
Elhakeem, Ahmed
Feresu, Shingairai A.
Maseko, Fresier
Chipato, Tsungai
author_sort Mapanga, Witness
collection PubMed
description BACKGROUND: Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developing countries has not been reviewed. The aim of this study is to systematically review cervical cancer prevention modalities available for HIV-seropositive women in developing countries. METHODS/DESIGN: This protocol was developed by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement, and the systematic review will be reported in accordance with the PRISMA guidelines. Embase, MEDLINE, PubMed, CINAHL and Cochrane Library will be searched from inception up to date of final search, and additional studies will be located through citation and reference list tracking. Eligible studies will be randomised controlled trials, prospective and retrospective cohort studies, case-control and cross-sectional studies carried out in developing countries. Studies will be included if they are published in English and examine cervical cancer prevention modalities in HIV-seropositive women. Results will be summarised in tables and, where appropriate, combined using meta-analysis. DISCUSSION: This review will address the gap in evidence by systematically reviewing the published literature on the different prevention modalities being used to prevent cervical cancer in HIV-seropositive women in developing countries. The findings may be used to inform evidence-based guidelines for prevention of cervical cancer in seropositive women as well as future research. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017054678. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0484-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5404686
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54046862017-04-27 Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol Mapanga, Witness Elhakeem, Ahmed Feresu, Shingairai A. Maseko, Fresier Chipato, Tsungai Syst Rev Protocol BACKGROUND: Over 85% of cervical cancer cases and deaths occur in developing countries. HIV-seropositive women are more likely to develop precancerous lesions that lead to cervical cancer than HIV-negative women. However, the literature on cervical cancer prevention in seropositive women in developing countries has not been reviewed. The aim of this study is to systematically review cervical cancer prevention modalities available for HIV-seropositive women in developing countries. METHODS/DESIGN: This protocol was developed by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement, and the systematic review will be reported in accordance with the PRISMA guidelines. Embase, MEDLINE, PubMed, CINAHL and Cochrane Library will be searched from inception up to date of final search, and additional studies will be located through citation and reference list tracking. Eligible studies will be randomised controlled trials, prospective and retrospective cohort studies, case-control and cross-sectional studies carried out in developing countries. Studies will be included if they are published in English and examine cervical cancer prevention modalities in HIV-seropositive women. Results will be summarised in tables and, where appropriate, combined using meta-analysis. DISCUSSION: This review will address the gap in evidence by systematically reviewing the published literature on the different prevention modalities being used to prevent cervical cancer in HIV-seropositive women in developing countries. The findings may be used to inform evidence-based guidelines for prevention of cervical cancer in seropositive women as well as future research. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017054678. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0484-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-24 /pmc/articles/PMC5404686/ /pubmed/28438187 http://dx.doi.org/10.1186/s13643-017-0484-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Protocol
Mapanga, Witness
Elhakeem, Ahmed
Feresu, Shingairai A.
Maseko, Fresier
Chipato, Tsungai
Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
title Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
title_full Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
title_fullStr Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
title_full_unstemmed Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
title_short Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol
title_sort prevention of cervical cancer in hiv-seropositive women from developing countries: a systematic review protocol
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404686/
https://www.ncbi.nlm.nih.gov/pubmed/28438187
http://dx.doi.org/10.1186/s13643-017-0484-9
work_keys_str_mv AT mapangawitness preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol
AT elhakeemahmed preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol
AT feresushingairaia preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol
AT masekofresier preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol
AT chipatotsungai preventionofcervicalcancerinhivseropositivewomenfromdevelopingcountriesasystematicreviewprotocol